Company Overview of Venture Biodiscovery, Inc.
Venture Biodiscovery, Inc. (VB) is in the process of establishing a new laboratory in Florida and obtaining governmental permits to set up and focus on the biological control of microbial diseases affecting plants and animals. In February 2002, Gatlin Holdings, Inc. (OTCBB: GTNH) completed its acquisition of Venture Biodiscovery, Inc. as a wholly owned subsidiary.
Key Executives for Venture Biodiscovery, Inc.
Venture Biodiscovery, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Venture Biodiscovery, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.